Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

erippetoe

From: scorman1	1/14/2025 9:44:44 PM
	1 Recommendation of 63304

Just an observation: Biogen market cap today just bottomed at $20+ bill or roughly the price we were paid for IMMU.... I was always PO'd that IDEC got Zevalin to market before us and it was going to open the gate for us to get approval.... never happened, not with Coleman coming on board for NHL, or other failures like lupus, CEAcide, etc. Psychologists will say that it is not sufficient to simply succeed, but your opponents must fail.... I feel some sort of vindication with Biogen hitting new lows.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next